Cancer Care in Korea: How an American Patient Overcame an Insurance Delay

 

A real case from Asan Medical Center: A U.S. patient with renal pelvis cancer faced a delay in starting anticancer treatment because of overseas insurance authorization. Here is how the hospital’s international care team helped.

When a Cancer Diagnosis Meets an Insurance Problem

A woman in her 60s from the United States was admitted to Asan Medical Center in Seoul through the emergency department. She had been diagnosed with a malignant tumor of the renal pelvis, described in the hospital's account as transitional cell carcinoma. The renal pelvis is the part of the urinary tract that collects urine inside the kidney. Cancer arising in its lining is often classified as upper tract urothelial carcinoma. The patient's treating team determined that systemic anticancer treatment needed to begin promptly.

1. Why Treatment Was Delayed

According to a firsthand account published by an international insurance and billing manager at Asan Medical Center, the patient faced a financial obstacle before treatment could begin. Because she was not covered by South Korea's National Health Insurance, international-patient charges applied. The anticipated cost was substantial, and she was understandably worried about paying for treatment. Her planned chemotherapy was delayed by approximately one week. The report does not give the patient's cancer stage, the names of the medicines, or a numerical treatment estimate.

2. The International Care Team Stepped In

Jennifer Choi, an overseas insurance and billing manager at the hospital's International Healthcare Center, took responsibility for contacting the patient's overseas insurer. She requested a guarantee of payment—a confirmation from the insurer that eligible hospital charges would be covered under the applicable policy. The time difference complicated the process: the insurer's business hours corresponded to approximately 9:30 p.m. to 6:30 a.m. in Korea. For two days, there was no answer. Choi continued calling and emailing during early-morning hours while the patient waited anxiously.

3. Approval That Allowed Treatment to Proceed

The hospital eventually obtained the insurer's approval for urgent processing. According to Choi's account, this resolved the immediate payment-authorization obstacle and helped the patient begin the prescribed anticancer treatment. The patient and her accompanying family member thanked the coordinator for her efforts. This is an account of overcoming an administrative barrier to treatment; it is not evidence of a particular tumor response or cure.

4. Why This Matters to Patients Considering Korea

International cancer care depends on more than access to specialists and medicines. A patient may need an insurer's preauthorization, a payment guarantee, an upfront deposit, or a written estimate before a hospital can proceed with a planned course of treatment. In urgent situations, delays in paperwork can become a source of serious stress. This case shows how a dedicated international patient team can coordinate between clinicians, a patient, and an insurer across time zones. It does not mean every overseas insurance policy is accepted or that authorization can always be obtained.

5. Understanding Renal Pelvis Cancer

The renal pelvis is part of the upper urinary tract. Tumors in this location are often urothelial cancers, which are related to—but distinct in location from—bladder cancer. Treatment may include surgery, systemic anticancer medicines, or other approaches depending on the stage, the patient's kidney function, and overall health. In this reported case, the hospital described the planned treatment as chemotherapy. Because no detailed treatment protocol was published, we cannot identify the drugs used or explain why that regimen was chosen for this particular patient.

6. What International Patients Can Prepare

Patients who already have a cancer diagnosis can make the first discussion with a Korean hospital more productive by preparing pathology reports, scans, treatment summaries, a current medication list, and details of their insurance coverage. Before traveling, ask the hospital whether it can review records remotely, whether the insurer has a direct-billing arrangement, and whether a guarantee of payment or deposit is required. Also ask who will coordinate follow-up care after returning home. For urgent or worsening symptoms, seek immediate local medical attention rather than waiting for international travel arrangements.

7. What We Know—and What We Do Not

The source is a firsthand narrative written by a hospital international-care employee and published by Asan Medical Center on December 23, 2022. It describes a U.S. patient in her 60s, renal pelvis cancer, an approximately one-week delay, persistent insurer communication, and eventual payment authorization. The patient's name, nationality, exact treatment bill, drug regimen, long-term outcome, and current health status were not disclosed. We therefore present this as a documented care-coordination case, not as a verified cancer-remission story or a cost-saving comparison.

The Larger Lesson

For a patient facing cancer abroad, the difference between having a treatment plan and starting that treatment can sometimes depend on practical coordination. In this case, the hospital's international team helped remove an insurance-related obstacle so that prescribed treatment could proceed. Korea Medical Compass shares such stories to help patients ask better questions, understand real-world challenges, and make informed decisions—not to promise a particular medical result.

Primary source

Asan Medical Center Newsroom, “[Thank U, AMC] The Promise Made,” December 23, 2022. Written by Jennifer Choi, overseas insurance and billing manager, International Healthcare Center.

This article summarizes and contextualizes the published account. It does not independently verify private medical records or insurance documents.

Medical disclaimer: Educational information only; not medical advice. Cancer treatment and timing require evaluation by qualified medical professionals.

Editorial independence: Korea Medical Compass is an independent informational blog. This is not a sponsored hospital advertisement, and no referral commission is received.

Image disclosure: The featured image is AI-generated and does not depict the actual patient or staff.